I25
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Availability of images from at least 64-slice cardio-CT scanner. Documentation of lipid-lowering therapy at time of serial cardio-CT scan.
Exclusion criteria
Exclusion criteria: Pregnancy/Lactation. Patients without atherosclerotic lesions at baseline and follow-up. Patients undergoing PCI or CABG between the 2 CCTA scans.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serial quantitative evaluation of plaque burden and composition in patients with no/low versus moderate and high-dose lipid-lowering therapy. Evaluation of the impact of different intensities of lipid-lowering treatment on high-risk plaque features and pericoronary adipose tissue attenuation (PCAT) | — |
Secondary
| Measure | Time frame |
|---|---|
| Verification of results by analysis of inter- and intraobserver (>4 weeks) variability. | — |
Countries
Germany, Hungary, Switzerland
Contacts
GRN-Klinikum Weinheim